Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors (Q37889247)

24 August 2017

1 reference

title

Adjuvant and neoadjuvant imatinib therapy: current role in the management of gastrointestinal stromal tumors (English)

1 reference

24 August 2017

1 reference

Burton L Eisenberg

1

1 reference

PubMed ID

21671474

24 August 2017

Jonathan C Trent

series ordinal

2

1 reference

PubMed ID

21671474

24 August 2017

language of work or name

English

0 references

publication date

1 December 2011

1 reference

24 August 2017

10

1 reference

International Journal of Cancer

inferred from page(s)

published in

1 reference

24 August 2017

129

1 reference

24 August 2017

11

1 reference

24 August 2017

2533-2542

1 reference

Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study.

24 August 2017

1 reference

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study.

21 January 2018

1 reference

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

21 January 2018

1 reference

Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain

21 January 2018

1 reference

The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000.

21 January 2018

1 reference

Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study.

21 January 2018

1 reference

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

21 January 2018

1 reference

PDGFRA activating mutations in gastrointestinal stromal tumors.

21 January 2018

1 reference

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

21 January 2018

1 reference

Molecular pathobiology of gastrointestinal stromal sarcomas.

21 January 2018

1 reference

Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

21 January 2018

1 reference

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

21 January 2018

1 reference

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.

21 January 2018

1 reference

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

21 January 2018

1 reference

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

21 January 2018

1 reference

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors

21 January 2018

1 reference

An audit of surgical management of gastrointestinal stromal tumours (GIST).

21 January 2018

1 reference

Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours

21 January 2018

1 reference

Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site

21 January 2018

1 reference

Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

21 January 2018

1 reference

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

21 January 2018

1 reference

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients.

21 January 2018

1 reference

A malignant omental extra-gastrointestinal stromal tumor on a young man: a case report and review of the literature

21 January 2018

1 reference

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).

21 January 2018

1 reference

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib

21 January 2018

1 reference

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

21 January 2018

1 reference

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

Post-operative imatinib in patients with intermediate or high risk gastrointestinal stromal tumor

21 January 2018

1 reference

A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis

21 January 2018

1 reference

Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.

21 January 2018

1 reference

Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor

21 January 2018

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate

21 January 2018

1 reference

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

21 January 2018

1 reference

Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively

21 January 2018

1 reference

12 December 2020

Perforated GIST of the small intestine as a rare cause of acute abdomen: Surgical treatment and adjuvant therapy. Case report.

1 reference

12 December 2020

Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors

1 reference

12 December 2020

Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging

1 reference

12 December 2020

Surgical resection of gastrointestinal stromal tumors after treatment with imatinib

1 reference

12 December 2020

Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report.

1 reference

12 December 2020

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

12 December 2020

Biological and clinical review of stromal tumors in the gastrointestinal tract

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.26234

1 reference

24 August 2017

1 reference

PubMed ID

21671474